The diaryl oxazole PC-046 is a tubulin-binding agent with experimental anti-tumor efficacy in hematologic cancers

By Landowski Terry   Samulitis Betty   Dorr Robert  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1616-1625

Springer Publishing Company

Access to resources Recommend Favorite

Co-solvent solubilization of some poorly-soluble antidiabetic drugs

By Seedher Neelam   Kanojia Mamta  

Pharmaceutical Development and Technology, Vol. 14, Iss. 2, 2009-04 ,pp. : 185-192

Informa Healthcare

Access to resources Recommend Favorite

Mechanisms of action and resistance to tubulin-binding agents

By Dumontet C.  

Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. : 779-788

Informa Healthcare

Access to resources Recommend Favorite

The effects of tubulin-binding agents on stretch-induced ventricular arrhythmias

By Parker K.K.   Taylor L.K.   Atkinson B.   Hansen D.E.   Wikswo J.P.  

European Journal of Pharmacology, Vol. 417, Iss. 1, 2001-04 ,pp. : 131-140

Elsevier

Access to resources Recommend Favorite

Small-molecule, tubulin-binding compounds as vascular targeting agents

By Marx Matthew A  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 769-776

Informa Healthcare

Access to resources Recommend Favorite